The study mainly investigates the therapeutic effect of Heart-Protecting Musk Pill (HMP) on patients with diabetic microangiopathy.
According to the indicators of diabetic nephropathy (DN), diabe ...

: Diabetes Mellitus, Type 2

To compare treatment with Aspirin Protect� twice a day (100 mg in the morning and 100 mg in the evening) versus Aspirin Protect� 100 mg once per day on a composite end-point of ischemic events in diab ...

: Diabetes Mellitus

The HEARTS Technical Package was developed by the World Health Organization to address the implementation gap of cardiovascular disease prevention in low- and middle-income countries.
Guatemala i ...

: Diabetes Mellitus, Type 2

Background: The coexistence of heart failure and diabetes is prevalent, particularly in Intensive Care Units (ICU). However, the relationship between the triglyceride-glucose (TyG) index, heart failur

Background and aims: Cystic fibrosis related diabetes (CFRD) is correlated with worsening of nutritional status and greater deterioration of lung function. The role of new technologies for the treatme

Background: Central retinal artery occlusion (CRAO) is a medical condition characterized by sudden blockage of the central retinal artery, which leads to a significant and often irreversible loss of v